semaglutide loss of exclusivity Ozempic's patent problem: how Novo Nordisk lost control a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Off-patent semaglutide in 2026: the
Pay in 4 interest-free payments of $5.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 18 - Nov 23

















.png?width=1280&auto=webp&quality=80&format=jpg&disable=upscale)







